#drugdevelopment #Clinicaltrials #RandD #clinicalresearch #neurodegeneration #regenerativemedicine #clinicaltrialdevelopments #orphandrugdesignation #preclinicaldata #fasttrackdesignation #expandedaccess #FDApriorityreview #clinicalprogress #strategicfunding
zurl.co/jmZiW
zurl.co/jmZiW
Q3 Clinical trials round-up: July to September 2025
As the third quarter of 2025 draws to a close, the clinical research landscape has been marked by a surge of promising data and regulatory milestones.
zurl.co
October 15, 2025 at 11:15 AM
#AlzeCure #AlzeCurePharmaAB #NeuroRestoreACD856 #Preclinicaldata #Alzheimersdisease #AD #ACD856 #biomarkers #diseasemodifyingpotential #NeuroRestorecompounds #NeuroRestoreplatform #Parkinsonsdisease #depression #Alzheimers #Parkinsons #NeurologicalDiseases
pharmatimes.com/news/alzecur...
pharmatimes.com/news/alzecur...
AlzeCure's NeuroRestore ACD856 to be presented at AD/PD 2025 - PharmaTimes
Preclinical data highlights potential in treating Alzheimer's disease
pharmatimes.com
January 21, 2025 at 1:55 PM
NEWS: Lyon, France-based late-stage clinical #biotech #MaaTPharma has presented new #preclinicaldata for MaaT034 at the #AmericanAssociationforCancerResearch annual meeting 2025 in Chicago, US – with compelling anti-tumour efficacy results.
pharmaphorum.com/news/aacr-20...
pharmaphorum.com/news/aacr-20...
AACR 2025: MaaT Pharma, the gut microbiome, and immuno-oncology
Lyon, France-based late-stage clinical biotech MaaT Pharma has presented new preclinical data for MaaT034 at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago.
pharmaphorum.com
April 29, 2025 at 9:45 AM
NEWS: Lyon, France-based late-stage clinical #biotech #MaaTPharma has presented new #preclinicaldata for MaaT034 at the #AmericanAssociationforCancerResearch annual meeting 2025 in Chicago, US – with compelling anti-tumour efficacy results.
pharmaphorum.com/news/aacr-20...
pharmaphorum.com/news/aacr-20...